AQR Capital Management
IRD

AQR Capital Management’s Opus Genetics IRD Stock Holding History

AQR Capital Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-77
Closed -$22K – 2274
2015
Q2 		$22K Sell
77
-217
-74% -$73.7K ﹤0.01% 2204
2015
Q1 		$103K Sell
294
-152
-34% -$55.2K ﹤0.01% 2076
2014
Q4 		$150K Hold
446
– – ﹤0.01% 2409
2014
Q3 		$173K Hold
446
– – ﹤0.01% 2382
2014
Q2 		$186K Sell
446
-347
-44% -$158K ﹤0.01% 2390
2014
Q1 		$411K Buy
+793
New +$429K ﹤0.01% 2140

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AQR Capital Management's IRD Position: Q3 2015 in Review

AQR Capital Management sold out of Opus Genetics (IRD) in Q3 2015, closing a stake of 77 shares — an estimated $22K sold.

AQR Capital Management first reported a position in IRD in Q1 2014 and held it in 6 quarters. The position peaked at $411K in Q1 2014. 31 funds tracked by Wall St. Rank hold IRD as of Q3 2015.

  • AQR Capital Management reported no remaining Opus Genetics position as of Q3 2015 after selling out during the quarter.
  • AQR Capital Management sold 77 Opus Genetics shares in Q3 2015, an estimated $22K.
  • AQR Capital Management first reported a position in Opus Genetics in Q1 2014 and held it in 6 quarters.
  • AQR Capital Management's Opus Genetics position peaked at $411K in Q1 2014.
  • 31 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2015.

Based on AQR Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.